Klebsiella pneumoniae Population Genomics and Antimicrobial-Resistant Clones

Trends in Microbiology

Volumn 24, Issue 12, 2016, Pages 944-956

  Wyres, Kelly L ^a,b   Holt, Kathryn E ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

antimicrobial resistance; genomics; Klebsiella pneumoniae; population structure

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

AAC GENE; AADA GENE; AADB GENE; ANTIBIOTIC RESISTANCE; APH GENE; ARMA GENE; ARR GENE; BACTERIAL GENE; BACTERIAL STRAIN; CATA GENE; CATB GENE; CML GENE; DFR GENE; DISEASE TRANSMISSION; EREA GENE; EREB GENE; ESCHERICHIA COLI; FLOR GENE; FOLP GENE; GENETIC VARIABILITY; GENOMICS; HOMOLOGOUS RECOMBINATION; HUMAN; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; KLEBSIELLA QUASIPNEUMONIAE; KLEBSIELLA VARIICOLA; MCR1 GENE; MCR1.2 GENE; MEF GENE; MOLECULAR CLONING; MOLECULAR DYNAMICS; MPH GENE; MSRE GENE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PHYLOGENY; POPULATION STRUCTURE; PRIORITY JOURNAL; QEPA GENE; QNRA GENE; QNRB GENE; QNRD GENE; QNRS GENE; REVIEW; RMT GENE; SALMONELLA ENTERICA; SINGLE NUCLEOTIDE POLYMORPHISM; STRAB GENE; SUL1 GENE; SUL2 GENE; SUL3 GENE; TET GENE; TRANSPOSON; DRUG EFFECTS; EPIDEMIC; GENETICS; KLEBSIELLA INFECTIONS; METABOLISM; METAGENOMICS; MICROBIOLOGY; MOLECULAR EVOLUTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; METAGENOMICS;

EID: 84997190990     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.09.007     Document Type: Review

References (107)

1. 1 Bagley, S.T., Habitat association of Klebsiella species. Infect. Contr. 6 (1985), 52–58.
2. 2 Podschun, R., Ullmann, U., Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11 (1998), 589–603.
3. 3 Jones, R.N., Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin. Infect. Dis. 51 (2010), S81–S87.
4. 4 Pendleton, J.N., et al. Clinical relevance of the ESKAPE pathogens. Exp. Rev. Anti Infect. Ther. 11 (2013), 297–308.
5. 5 World Health Organization. Antimicrobial Resistance: Global Report on Surveillance., 2014, WHO.
6. 6 Chaves, J., et al. SHV-1 β-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45 (2001), 2856–2861.
7. 7 Sirot, J., et al. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Clin. Infect. Dis. 10 (1988), 850–859.
8. 8 Nordmann, P., et al. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9 (2009), 228–236.
9. 9 Nordmann, P., et al. The emerging NDM carbapenemases. Trends Microbiol. 19 (2011), 588–595.
10. 10 Liu, Y.Y., et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16 (2016), 161–168.
11. 11 Diancourt, L., et al. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43 (2005), 4178–4182.
12. 12 Brisse, S., et al. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One, 4, 2009, e4982.
13. 13 Maiden, M.C.J., Multilocus sequence typing of bacteria. Annu. Rev. Microbiol. 60 (2006), 561–588.
14. 14 Bialek-Davenet, S., et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg. Infect. Dis. 20 (2014), 1812–1820.
15. 15 Jolley, K.A., Maiden, M.C., BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics., 10, 2010, 595.
16. 16 Holt, K.E., et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E3574–E3581.
17. 17 Snitkin, E.S., et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci. Transl. Med., 4, 2012, 148ra116.
18. 18 The, H.C., et al. A high-resolution genomic analysis of multidrug- resistant hospital outbreaks of Klebsiella pneumoniae. EMBO Molec. Med. 7 (2015), 227–239.
19. 19 Bowers, J.R., et al. Genomic analysis of the emergence and rapid global dissemination of the clonal group 258 Klebsiella pneumoniae pandemic. PLoS One, 10, 2015, e0133727.
20. 20 Zhou, K., et al. Use of whole-genome sequencing to trace, control and characterize the regional expansion of extended-spectrum β-lactamase producing ST15 Klebsiella pneumoniae. Sci. Rep., 6, 2016, 20840.
21. 21 Stoesser, N., et al. Genome sequencing of an extended series of NDM-producing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic setting. Antimicrob. Agents Chemother. 58 (2014), 7347–7357.
22. 22 Marsh, J.W., et al. Genomic epidemiology of an endoscope-associated outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. PLoS One, 10, 2015, e0144310.
23. 23 Deleo, F.R., et al. Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 4988–4993.
24. 24 Struve, C., et al. Mapping the evolution of hypervirulent Klebsiella pneumoniae. mBio 6 (2015), 1–12.
25. 25 Brisse, S., et al. Description of Klebsiella quasipneumoniae sp. nov., isolated from human infections, with two subspecies, Klebsiella quasipneumoniae subsp. quasipneumoniae subsp. nov. and Klebsiella quasipneumoniae subsp. similipneumoniae subsp. nov., and demonstration that Klebsiella singaporensis is a junior heterotypic synonym of Klebsiella variicola. Int. J. Syst. Evol. Microbiol. 64 (2014), 3146–3152.
26. 26 Rosenblueth, M., et al. Klebsiella variicola, a novel species with clinical and plant-associated isolates. Syst. Appl. Microbiol. 27 (2004), 27–35.
27. 27 Chen, L., et al. Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. mBio 5 (2014), e01355–e1414.
28. 28 Wyres, K.L., et al. Extensive capsule locus variation and large-scale genomic recombination within the Klebsiella pneumoniae clonal group 258. Genome Biol. Evol. 7 (2015), 1267–1279.
29. 29 Vos, M., Didelot, X., A comparison of homologous recombination rates in bacteria and archaea. ISME J. 3 (2009), 199–208.
30. 30 Follador, R., et al. The diversity of Klebsiella pneumoniae surface polysaccharides. MGen, 2016, 2, 10.1099/mgen.0.000073 Published online August 25, 2016.
31. 31 Edwards, P.R., Fife, M.A., Capsule types of Klebsiella. J. Infect. Dis. 91 (1952), 92–104.
32. 32 Edmunds, P.N., Further Klebsiella capsule types. J. Infect. Dis. 94 (1954), 65–71.
33. 33 Ørskov, I.D.A., Fife-Asbury, M.A., New Klebsiella capsular antigen, K82, and the deletion of five of those previously assigned. Int. J. Syst. Bacteriol. 27 (1977), 386–387.
34. 34 Pan, Y-J., et al. Genetic analysis of capsular polysaccharide synthesis gene clusters in 79 capsular types of Klebsiella spp. Nat. Sci. Rep., 5, 2015, 15573.
35. 35 Medini, D., et al. The microbial pan-genome. Curr. Opin. Genet. Dev. 15 (2005), 589–594.
36. 36 Ramirez, M.S., et al. Plasmid-mediated antibiotic resistance and virulence in Gram-negatives: the Klebsiella pneumoniae paradigm. Microbiol. Spectr. 2 (2014), 1–15.
37. 37 Bojer, M.S., et al. ClpP-dependent and -independent activities encoded by the polycistronic ClpK-encoding locus contribute to heat shock survival in Klebsiella pneumoniae. Res. Microbiol. 164 (2013), 205–210.
38. 38 Löhr, I.H., et al. Persistence of a pKPN3-like CTX-M-15-encoding IncFIIK plasmid in a Klebsiella pneumoniae ST17 host during two years of intestinal colonization. PLoS One, 10, 2015, e0116516.
39. 39 Paczosa, M.K., Mecsas, J., Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol. Mol. Biol. Rev. 80 (2016), 629–661.
40. 40 Iredell, J., et al. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. BMJ, 352, 2016, h6420.
41. 41 Conlan, S., et al. Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci. Transl. Med., 6, 2014, 254ra126.
42. 42 Mathers, A.J., et al. Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from whole-genome sequencing. Antimicrob. Agents Chemother. 59 (2015), 1656–1663.
43. 43 Mathers, A.J., et al. Molecular dissection of an outbreak of carbapenem-resistant Enterobacteriaceae reveals intergenus KPC carbapenemase transmission through a promiscuous plasmid. mBio 2 (2011), e00204–e00211.
44. 44 Sheppard, A.E., et al. Nested Russian doll-like genetic mobility drives rapid dissemination of the carbapenem resistance gene blaKPC. Antimicrob. Agents Chemother. 60 (2016), 3767–3778.
45. 45 Mshana, S.E., et al. Molecular epidemiology and characterization of an outbreak causing Klebsiella pneumoniae clone carrying chromosomally located blaCTX-M-15 at a German University-Hospital. BMC Microbiol., 15, 2015, 122.
46. 46 Zowawi, H.M., et al. Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae. Sci. Rep., 5, 2015, 15082.
47. 47 Chen, L., et al. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 22 (2014), 686–696.
48. 48 Lee, C-R., et al. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front. Microbiol. 7 (2016), 1–30.
49. 49 Conlan, S., et al. Plasmid dynamics in KPC-positive Klebsiella pneumoniae during long-term patient colonization. mBio 7 (2016), e00742–e816.
50. 50 Adler, A., et al. Dissemination of the blaKPC gene by clonal spread and horizontal gene transfer: comparative study of incidence and molecular mechanisms. J. Antimicrob. Chemother. 71 (2016), 2143–2146.
51. 51 Poirel, L., et al. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob. Agents Chemother. 56 (2012), 559–562.
52. 52 Potron, A., et al. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Eur. Surveill., 18, 2013, 20549.
53. 53 Czobor, I., et al. Efficient transmission of IncFIIY and IncL plasmids and Klebsiella pneumoniae ST101 clone producing OXA-48, NDM-1 or OXA-181 in Bucharest hospitals. Int. J. Antimicrob. Agents 48 (2016), 223–224.
54. 54 Pérez-Vázquez, M., et al. Phylogeny, resistome and mobile genetic elements of emergent OXA-48 and OXA-245 Klebsiella pneumoniae clones circulating in Spain. J. Antimicrob. Chemother. 71 (2016), 887–896.
55. 55 Doi, Y., et al. Whole-genome assembly of Klebsiella pneumoniae coproducing NDM-1 and OXA-232 carbapenemases using single-molecule, real-time sequencing. Antimicrob. Agents Chemother. 58 (2014), 5947–5953.
56. 56 Chen, C.J., et al. Closely related NDM-1-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. PLoS One 9 (2014), 1–6.
57. 57 Coelho, A., et al. Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration. Int. J. Antimicrob. Agents 36 (2010), 73–78.
58. 58 Markovska, R., et al. Predominance of IncL/M and IncF plasmid types among CTX-M-ESBL-producing Escherichia coli and Klebsiella pneumoniae in Bulgarian hospitals. Apmis 122 (2014), 608–615.
59. 59 Dolejska, M., et al. Plasmid content of a clinically relevant Klebsiella pneumoniae clone from the Czech Republic producing CTX-M-15 and QnrB1. Antimicrob. Agents Chemother. 57 (2013), 1073–1076.
60. 60 Padilla, E., et al. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob. Agents Chemother. 54 (2010), 177–183.
61. 61 Bialek-Davenet, S., et al. Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae. J. Antimicrob. Chemother. 70 (2015), 81–88.
62. 62 Martinez-Martinez, L., Extended-spectrum beta-lactamases and the permeability barrier. Clin. Microbiol. Infect. 14:Suppl. 1 (2008), 82–89.
63. 63 Weigel, L.M., et al. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42 (1998), 2661–2667.
64. 64 Chen, F., et al. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae. Microb. Drug Res. 9 (2003), 265–271.
65. 65 Tsai, Y.K., et al. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob. Agents Chemother. 55 (2011), 1485–1493.
66. 66 Tóth, A., et al. Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum β-lactamase. Eur. J. Clin. Microbiol. Infect. Dis. 33 (2014), 837–843.
67. 67 Doi, Y., Paterson, D.L., Carbapenemase-producing Enterobacteriaceae. Semin. Respir. Crit. Care Med. 36 (2015), 74–84.
68. 68 Cannatelli, A., et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob. Agents Chemother. 57 (2013), 5521–5526.
69. 69 Jayol, A., et al. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob. Agents Chemother. 58 (2014), 4762–4766.
70. 70 Poirel, L., et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J. Antimicrob. Chemother. 70 (2015), 75–80.
71. 71 Cheng, Y-H., et al. Amino acid substitutions of CrrB responsible for resistance to colistin through CrrC in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 60 (2016), 3709–3716.
72. 72 Di Pilato, V., et al. MCR-1.2: a new MCR variant encoded by a transferable plasmid from a colistin-resistant KPC carbapenemase-producing Klebsiella pneumoniae of sequence type 512. Antimicrob. Agents Chemother. 60 (2016), 5612–5615.
73. 73 Cannatelli, A., et al. Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 59 (2015), 2898–28900.
74. 74 Arena, F., et al. Colistin resistance caused by inactivation of the MgrB regulator is not associated with decreased virulence of sequence type 258 KPC carbapenemase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 60 (2016), 2509–2512.
75. 75 Giani, T., et al. Large nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J. Clin. Microbiol. 53 (2015), 3341–3344.
76. 76 Hentschke, M., et al. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Antimicrob. Agents Chemother. 54 (2010), 2720–2723.
77. 77 Roy, S., et al. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility. J. Antimicrob. Chemother. 68 (2013), 1036–1042.
78. 78 Ruzin, A., et al. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 49 (2005), 1017–1022.
79. 79 Villa, L., et al. Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrob. Agents Chemother. 58 (2014), 1707–1712.
80. 80 Gaiarsa, S., et al. Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics. Antimicrob. Agents Chemother. 59 (2015), 389–396.
81. 81 Munoz-Price, L.S., et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect. Dis. 13 (2013), 785–796.
82. 82 Pitout, J.D.D., et al. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob. Agents Chemother. 59 (2015), 5873–5884.
83. 83 Lian-Hui, W., et al. Diversity of the genetic environment of the blaKPC-2 gene among Klebsiella pneumoniae clinical isolates in a Chinese hospital. Microb. Drug Res. 22 (2016), 15–21.
84. 84 Pereira, P.S., et al. Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J. Antimicrob. Chemother. 68 (2013), 312–316.
85. 85 Baraniak, A., et al. NDM-producing Enterobacteriaceae in Poland, 2012-14: inter-regional outbreak of Klebsiella pneumoniae ST11 and sporadic cases. J. Antimicrob. Chemother. 71 (2016), 85–91.
86. 86 Wright, M.S., et al. Population Structure of KPC-producing Klebsiella pneumoniae from Midwestern US hospitals. Antimicrob. Agents Chemother 58 (2014), 4961–4965.
87. 87 Kitchel, B., et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 53 (2009), 3365–3370.
88. 88 Deshpande, L.M., et al. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb. Drug Res. 12 (2006), 223–230.
89. 89 Adler, A., et al. A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone. J. Clin. Microbiol. 50 (2012), 3180–3185.
90. 90 Thomas, C.P., et al. Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK. Int. J. Antimicrob. Agents 42 (2013), 531–536.
91. 91 Sánchez-Romero, I., et al. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob. Agents Chemother. 56 (2012), 420–427.
92. 92 Balm, M.N.D., et al. OXA-181-producing Klebsiella pneumoniae establishing in Singapore. BMC Infect. Dis., 13, 2013, 58.
93. 93 Novais, A., et al. Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones. Eur. J. Clin. Microbiol. Infect. Dis. 31 (2012), 3057–3063.
94. 94 Stillwell, T., et al. Outbreak of KPC-3 producing carbapenem-resistant Klebsiella pneumoniae in a US pediatric hospital. J. Pediatr. Infect. Dis. 4 (2015), 330–338.
95. 95 Mammina, C., et al. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Eur. Surveill. 17 (2012), 1–6.
96. 96 Cubero, M., et al. Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital. BMC Microbiol., 15, 2015, 177.
97. 97 Hrabák, J., et al. International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum β-lactamases in a Czech hospital. J. Clin. Microbiol. 47 (2009), 3353–3357.
98. 98 Österblad, M., et al. Carbapenemase-producing enterobacteriaceae in Finland: the first years (2008-11). J. Antimicrob. Chemother. 67 (2012), 2860–2864.
99. 99 Marcade, G., et al. The emergence of multidrug-resistant Klebsiella pneumoniae of international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris region. Epidemiol. Infect. 141 (2012), 1705–1712.
100. 100 Bachman, M.A., et al. Genome-wide identification of Klebsiella pneumoniae fitness genes during lung infection. mBio, 6, 2015, e00775.
101. 101 Bruchmann, S., et al. Deep transcriptome profiling of clinical Klebsiella pneumoniae isolates reveals strain and sequence type-specific adaptation. Env. Microbiol. 17 (2015), 4690–4710.
102. 102 Larsen, M.V., et al. Multilocus sequence typing of total-genome-sequenced bacteria. J. Clin. Microbiol. 50 (2012), 1355–1361.
103. 103 Joensen, K.G., et al. Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J. Clin. Microbiol. 52 (2014), 1501–1510.
104. 104 Zankari, E., et al. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67 (2012), 2640–2644.
105. 105 Carattoli, A., et al. PlasmidFinder and pMLST: in silico detection and typing of plasmids. Antimicrob. Agents Chemother. 58 (2014), 3895–3903.
106. 106 Inouye, M., et al. SRST2: rapid genomic surveillance for public health and hospital microbiology labs. Genome Med., 6, 2014, 90.
107. 107 Hawkey, J., et al. ISMapper: identifying transposase insertion sites in bacterial genomes from short read sequence data. BMC Genomics, 16, 2015, 667.